EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Inflammation and Resolution in Obesity-Related Cardiovascular Disease

Paschalis Karakasis iD, Panagiotis Stachteas iD, Panagiotis Iliakis iD, Georgios Sidiropoulos, Konstantinos Grigoriou iD, Dimitrios Patoulias iD, Antonios P Antoniadis iD, Nikolaos Fragakis iD

International Journal of Molecular Sciences · 05.01.2026 · 27 (1) · 535

DOI: 10.3390/ijms27010535 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.01.2026. Verfasst von Paschalis Karakasis und 7 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Cardiology, Hippokration General Hospital, Aristotle University of Thessaloniki, Konstantinoupoleos 49, 54642 Thessaloniki, Gree…. Hauptthemen laut MEDLINE: Obesity, Inflammation, Cardiovascular Diseases. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity-associated inflammation underlies much of cardiometabolic pathology, reflecting the convergence of chronic, low-grade systemic immune activation with region-specific maladaptation of adipose depots. Among these, epicardial adipose tissue (EAT)—a visceral fat layer contiguous with the myocardium and sharing its microvasculature—functions as a cardio-proximal immunometabolic interface that influences atrial fibrillation, heart failure with preserved ejection fraction, and coronary atherogenesis through paracrine crosstalk. These relationships extend beyond crude measures of adiposity, emphasizing the primacy of local inflammatory signaling, adipokine flux, and fibro-inflammatory remodeling at the EAT–myocardium interface. Of importance, substantial weight reduction only partially reverses obesity-imprinted transcriptional and epigenetic programs across subcutaneous, visceral, and epicardial depots, supporting the concept of an enduring adipose memory that sustains cardiovascular (CV) risk despite metabolic improvement. Accordingly, therapeutic strategies should move beyond weight-centric management toward mechanism-guided interventions. Resolution pharmacology—leveraging specialized pro-resolving mediators and their cognate G-protein-coupled receptors—offers a biologically plausible means to terminate inflammation and reprogram immune–stromal interactions within adipose and CV tissues. Although preclinical studies report favorable effects on vascular remodeling, myocardial injury, and arrhythmic vulnerability, clinical translation is constrained by pharmacokinetic liabilities of native mediators and by incomplete validation of biomarkers for target engagement. This review integrates mechanistic, depot-resolved, and therapeutic evidence to inform the design of next-generation anti-inflammatory strategies for obesity-related CV disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityInflammationCardiovascular DiseasesHumansAnimalsEpicardial Adipose TissueAdipose Tissue

Stichwörter der Autor:innen

adipokinesatrial fibrillationcoronary artery diseaseheart failureinflammationobesityresolution pharmacology

Autor:innen und Institutionen

  • Second Department of Cardiology, Hippokration General Hospital, Aristotle University of Thessaloniki, Konstantinoupoleos 49, 54642 Thessaloniki, Greece.
  • First Cardiology Department, School of Medicine, Hippokration General Hospital, National and Kapodistrian University of Athens, 10679 Athens, Greece.
  • Department of Cardiology, Georgios Papanikolaou General Hospital, Leoforos Papanikolaou, 57010 Thessaloniki, Greece.
  • Department of Pharmacology, University of Athens, 75 Mikras Asias Avenue, 11527 Goudi, Greece.
  • Second Propedeutic Department of Internal Medicine, Faculty of Medicine, School of Health Sciences Aristotle, University of Thessaloniki, 54642 Thessaloniki, Greece.

ORCID-Profile: Paschalis Karakasis, Panagiotis Stachteas, Panagiotis Iliakis, Konstantinos Grigoriou, Dimitrios Patoulias, Antonios P Antoniadis, Nikolaos Fragakis

Zitieren

APA

Karakasis, P., Stachteas, P., Iliakis, P., Sidiropoulos, G., Grigoriou, K., Patoulias, D., Antoniadis, A. P., & Fragakis, N. (2026). Inflammation and Resolution in Obesity-Related Cardiovascular Disease. International Journal of Molecular Sciences, 27(1), 535. https://doi.org/10.3390/ijms27010535

Vancouver

Karakasis P, Stachteas P, Iliakis P, Sidiropoulos G, Grigoriou K, Patoulias D, et al. Inflammation and Resolution in Obesity-Related Cardiovascular Disease. International Journal of Molecular Sciences. 2026;27(1):535. doi:10.3390/ijms27010535

BibTeX
@article{Karakasis2026,
  author = {Karakasis, Paschalis and Stachteas, Panagiotis and Iliakis, Panagiotis and Sidiropoulos, Georgios and Grigoriou, Konstantinos and Patoulias, Dimitrios and Antoniadis, Antonios P and Fragakis, Nikolaos},
  title = {Inflammation and Resolution in Obesity-Related Cardiovascular Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {1},
  pages = {535},
  doi = {10.3390/ijms27010535}
}
Kostenlos starten →